Global Program Head For Dupilumab At Sanofi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CRISPR Therapeutics announced the appointment of Naimish Patel, M.D., as Chief Medical Officer, effective May 28, 2024. Dr. Patel is an experienced drug developer who has worked across a wide range of.

Julianne brunoNaimish patelGlobal development therapeutic area head of immunologyMcgill universityGlobal program head for dupilumab at sanofiPrinceton universityBeth israel deaconess medical centerCritical medicine at harvard medical schoolMckinsey companyWharton schoolVertex pharmaceuticalsChief medical officerGlobal development therapeutic area headChief operating officerSenior vice presidentGlobal program head